TuHURA Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HURA and other ETFs, options, and stocks.About HURA
TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. The firm’s lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors.
CEOJames A. Bianco
CEOJames A. Bianco
Employees19
Employees19
HeadquartersTampa, Florida
HeadquartersTampa, Florida
Founded2023
Founded2023
Employees19
Employees19
HURA Key Statistics
Market cap46.05M
Market cap46.05M
Price-Earnings ratio-1.12
Price-Earnings ratio-1.12
Dividend yield—
Dividend yield—
Average volume280.47K
Average volume280.47K
High today$0.7602
High today$0.7602
Low today$0.7073
Low today$0.7073
Open price$0.72
Open price$0.72
Volume339.33K
Volume339.33K
52 Week high$5.27
52 Week high$5.27
52 Week low$0.70
52 Week low$0.70
Stock Snapshot
With a market cap of 46.05M, TuHURA Biosciences(HURA) trades at $0.76. The stock has a price-to-earnings ratio of -1.12.
As of 2026-01-14, TuHURA Biosciences(HURA) stock has fluctuated between $0.71 and $0.76. The current price stands at $0.76, placing the stock +7.4% above today's low and -0.0% off the high.
The TuHURA Biosciences(HURA)'s current trading volume is 339.33K, compared to an average daily volume of 280.47K.
During the past year, TuHURA Biosciences(HURA) stock moved between $0.70 at its lowest and $5.27 at its peak.
During the past year, TuHURA Biosciences(HURA) stock moved between $0.70 at its lowest and $5.27 at its peak.
People also own
Based on the portfolios of people who own HURA. This list is generated using Robinhood data, and it’s not a recommendation.